BridgeBio Pharma (BBIO) Price to Sales (2019 - 2026)
Powered by 
Analysis
BridgeBio Pharma (BBIO) Price to Sales (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | BridgeBio Pharma | 14.65 Bn | 13.93 Bn | 228.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.69 |
| Mar 31, 2026 | 74.72 |
| Dec 31, 2025 | 96.63 |
| Sep 30, 2025 | 82.89 |
| Jun 30, 2025 | 74.66 |
| Mar 31, 2025 | 56.26 |
| Dec 31, 2024 | 886.57 |
| Sep 30, 2024 | 1,761.20 |
| Jun 30, 2024 | 2,196.90 |
| Mar 31, 2024 | 27.41 |
| Dec 31, 2023 | 4,050.49 |
| Sep 30, 2023 | 1,122.43 |
| Jun 30, 2023 | 1,691.91 |
| Mar 31, 2023 | 1,456.74 |
| Dec 31, 2022 | 613.78 |
| Sep 30, 2022 | 4,392.63 |
| Jun 30, 2022 | 18.25 |
| Mar 31, 2022 | 884.91 |
| Dec 31, 2021 | 245.77 |
| Sep 30, 2021 | 2,941.13 |